ReviewCancers2024

Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer.

Michael Dougan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.